Richard Gaynor, President of R&D at Neon Therapeutics, Inc. (NTGN), sold 65,322 shares at $1.31 ($85K) on 2019-11-26, disclosed to the SEC on 2019-11-27.
Open-market sale of $85k NTGN by President of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.37 | 20,000 | $27K | 32.2% |
| 2 | $1.31 | 23,000 | $30K | 35.4% |
| 3 | $1.24 | 22,322 | $28K | 32.5% |
| Total | $1.30 avg | 65,322 | $85K | 100% |
| Filing → |
| ZLAB | SELL | 2025-03-06 | $88K | — | Filing → |
| ZLAB | SELL | 2024-09-05 | $49K | — | Filing → |